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Abstract
 
Background
 
Neoplasia-induced lichen planus is described as a cell-mediated reaction to 
unknown epithelial antigens. Paraneoplastic pemphigus (PNP), characterized by the presence 
of a specific array of autoantibodies, probably represents a different form of presentation of the 
same autoimmune syndrome where the mucocutaneous expression depends on the dominant 
pathologic mechanism.
 
Methods
 
The authors report a case of PNP with predominant lichen planus-like lesions and 
review the relevant literature. We observed a 74-year-old female with vesico-bullous, erosive, 
target-shaped and flat papular lichenoid lesions on the lower legs, palms and soles, evolving for 
3 weeks. Histopathology revealed a lichenoid dermatitis. Direct immunofluorescence showed 
C3 deposition around keratinocytes and epidermal IgG intranuclear deposition. Indirect 
immunofluorescence revealed circulating IgG with intercellular staining on rat bladder substrate. 
Immunoblotting demonstrated bands of 130, 190, 210 and 250 kDa antigens. A pararenal B cell 
lymphoma was found.
 
Results
 
Oral corticotherapy with 40 mg prednisolone daily was initiated with a good cutaneous 
response. Four months later, cyclophosphamide (50 m
 
g
 
/day) was introduced because of a 
discrete enlargement of the pararenal mass. The patient died on the seventh month of follow up 
as a result of respiratory insufficiency.
 
Conclusion
 
PNP has different forms of presentation and the lack of a consensus about 
diagnostic criteria may contribute to underdiagnosed cases. Advances on the knowledge of the 
sensitivity and specificity of diagnostic criteria have allowed a better accuracy of diagnosis.
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Introduction
 
Paraneoplastic pemphigus (PNP) is an autoimmune bullous
disease with mucocutaneous involvement, individualized in
1990 by Anhalt 
 
et al
 
.
 
1
 
Before this nosological individualization, several cases
were reported in the literature as unusual pemphigus vulgaris,
unusual erythema multiforme or as unusual paraneoplastic
bullous diseases.
 
2,3
 
Since the first description, different forms of presentation
of PNP have been recognized and advances on the sensitivity
and specificity of the diagnostic criteria originally proposed
have been made.
We report a case of PNP with predominant lichen planus-
like lesions and review the relevant literature.
 
Case Report
 
We observed a 74-year-old White woman with mucocutane-
ous lesions evolving for a period of 3 weeks. She presented
with painful, erythemato-papular, vesico-bullous, erosive and
target-shaped lesions on the lower legs (Fig. 1), palms, soles
and abdomen along with flat-topped violaceous lichenoid
papules in the same distribution. Erosive and lichenoid
lesions of oral mucosa, lips and eyelids were also present.
Lichenoid lesions predominated and were found isolated, or
overlapping the other ones. She had mild conjunctivitis,
no genital involvement, and the physical examination was
otherwise normal. Her medical history was noncontributory.
The clinical impression was of lichen planus pemphigoid.
Histopathology of lichenoid and target lesions revealed
an interface cell-rich dermatitis, accompanied by dermal–
epidermal hydropic changes (Fig. 2). No acantholysis was
found. Direct immunofluorescence (DIF) on perilesional skin
displayed colloidal body deposition at the Dermoepidermal
junction (DEJ) and papillary dermis with IgG and C3, C3 focal
deposition in vessel walls of papillary dermis and around basal
keratinocytes, and focal epidermal IgG intranuclear deposition.
Indirect immunofluorescence (IIF) identified circulating IgG
with cell surface staining present to a titer of 1 : 10 on monkey
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esophagus and rat bladder (Fig. 3) along with nuclear epithe-
lial staining with IgG on normal skin and monkey esophagus.
The patient’s sera immunoprecipitated an antigenic complex
composed of several proteins – 130 kDa, 190 kDa, 210 kDa
and 250 kDa – that, respectively, correspond to desmoglein
3, periplakin, envoplakin and desmoplakin I (Fig. 4). All these
findings were consistent with paraneoplastic pemphigus.
Figure 3 Indirect immunofluorescence on rat bladder showing 
intercellular staining with IgG (stain type – Fluorescein; original 
magnification ×400)
Figure 4 Immunoprecipitation preparation demonstrating the 
characteristic pattern of PNP
Figure 1 Vesicles, erosions and target-shaped lesions on the 
lower leg. Some flat topped violaceous lichenoid papules are also 
observed
Figure 2 Histopathology in target lesion revealed an interface 
cell-rich dermatitis without acantholysis, accompanied by 
dermal–epidermal hydropic changes (stain type – Hematoxylin 
and eosin; original magnification ×100)
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A left pararenal mass of 6.5 
 
×
 
 4 cm was identified on CT
scan. Pathological examination of the mass revealed a low-
grade B cell lymphoma which was bcl2 positive, CD20 and
CD10 negative. The relevant abnormal laboratory findings
included a positive serum Antinuclear Antibodies (ANA) with
homogeneous pattern and an IgM lambda monoclonal gammo-
pathy. Oral corticotherapy with 40 mg prednisolone daily
was initiated along with topical application of betamethasone.
The lymphoma, at this time, was maintained on surveillance
and no specific treatment was initiated.
Almost complete clearing of lesions was observed by the
third month and tapering of prednisolone was therefore
undertaken. This did not modify the dermatological picture.
By the fourth month of follow up, warfarin (5 mg/day) and
cyclophosphamide (50 mg/day) were initiated, respectively,
as a result of a leg deep vein thrombosis and a discrete enlarge-
ment of the pararenal mass. Sparse lichenoid lesions were the
only cutaneous manifestation.
Two months latter she was hospitalized in another institu-
tion because of dyspnea and fatigue, dying from respiratory
failure after a few weeks. The arterial blood gas analysis and
chest radiography were inconsistent with the severity of the
dyspnea. The probable cause for this fatal pulmonary com-
plication was the development of obliterative bronchiolitis, as
reported in other similar cases. Unfortunately a biopsy for the
diagnosis of obliterant bronchiolitis was not undertaken.
 
Discussion
 
The mucocutaneous lesions of PNP have several clinical pres-
entations.
 
1,2,4
 
 Patients can present a pruritic skin eruption that
is bullous pemphigoid-like, with vesicles, bullae, erosions and
crusting, but can also have erythematous papules with central
vesiculation resembling erythema multiforme. The trunk,
proximal extremities, head and neck are the most commonly
affected regions, although in our patient they predominated
on the lower legs. Nikolsky sign can occasionally be elicited.
 
5
 
PNP spectrum also includes, a lichen planus pemphigoid-like
eruption that can precede or follow the symptoms of the neo-
plasm.
 
5–10
 
 Blisters and lichenoid lesions on the palms and
soles are frequently seen, helping to differentiate it from pem-
phigus vulgaris. An intractable stomatitis, similar to that of
pemphigus vulgaris, often confused with herpetic infection,
 
4
 
is usually the inaugural manifestation, with cutaneous lesions
developing shortly after.
 
1
 
 Pseudomembranous conjunctivitis
evolving to scaring is also frequent.
 
2,4
 
Lesions may also be found on laryngeal, nasopharyngeal,
esophageal, lingual, buccal, gingival, labial, gastrointestinal,
vaginal and penile mucosa.
 
2
 
Respiratory involvement with dyspnea resulting from
obliterant bronchiolitis is a frequent cause of death. This is
the consequence of intraluminal shedding of mucosal epithe-
lium, involved in the immune attack as a result of its richness
in desmoplakins.
 
2,4
 
 Patients usually have arterial blood gas
analysis and chest radiography inconsistent with the severity
of the dyspnea.
The disease has a broad geographic distribution, with sim-
ilar gender predominance and mean age of onset at around
51 years.
 
2
 
 Of the several neoplasms associated with PNP,
86% are lymphoproliferative disorders. The most commonly
found in decreasing order of frequency are
 
2
 
:
 
1
 
non-Hodgkin’s lymphoma;
 
2
 
chronic lymphocytic leukemia;
 
3
 
Castleman’s tumor;
 
4
 
thymoma (malignant and benign);
 
5
 
poorly-differentiated sarcoma;
 
6
 
Waldenström’s macroglobulinemia;
 
7
 
inflammatory fibrosarcoma;
 
8
 
bronchogenic squamous cell carcinoma;
 
9
 
round-cell liposarcoma;
 
10
 
Hodgkin’s disease; and
 
11
 
T cell lymphoma.
In one third of cases, the neoplasm is found after the devel-
opment of mucocutaneous disease.
 
2,3
 
On histological examination, suprabasilar acantholysis,
dermoepidermal cleavage, keratinocyte necrosis, epidermal
necrosis, interface changes with dense lichenoid infiltrate
in the papillary dermis and eosinophilic spongiosis, can be
found.
 
11
 
Direct immunofluorescence (DIF) on perilesional skin should
reveal IgG and/or C3 cell surface deposition, like in pemphigus
vulgaris, sometimes with sparse focal deposition. Granular-
linear deposits of C3 at the basement membrane zone may
also be seen.
 
2,11
 
 The possibility of false-negative results
demands, if necessary, repeated exams.
 
2
 
The IIF pattern is identical to that of pemphigus vulgaris
and pemphigus foliaceous, with staining of the epidermal cell
surface and/or basement membrane zone.
 
2,11,12
 
 Rat bladder is
the preferred substrate, because of its richness in desmosomes,
having a sensitivity of 86% and a specificity of 98% in the
screening of PNP.
 
2,11,13,14
 
 These antibodies can bind other
substrates with lower sensitivity and specificity.
 
2,13
 
 This may
explain why the PNP spectrum goes beyond the mucocutane-
ous manifestations and includes antibody deposition on
different organs namely respiratory epithelium, colon epithe-
lium, intercalated disks of myocardium, skeletal muscle and
thyroid epithelium.
 
2
 
Because of its specificity, IIF on rat bladder can be used
instead of immunoprecipitation studies.
 
11
 
PNP sera can recognize one or more of several proteins
(Table 1).
 
2,15
 
 It is probable that desmoglein 3, because of its
transmembrane location, will be the target antigen in PNP,
initiating the acantholytic process. Antibodies to desmoglein 3
have been proven to be pathogenic and it has been recently
demonstrated that they can be detected by ELISA in 100% of
the patients.
 
11,16
 
 This first attack would expose additional
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epitopes and will lead to the subsequent formation of anti-
bodies to the intracellular plakins (epitope spreading theory).
 
17
 
However, patients with pemphigus vulgaris do not have
antibodies to the plakin family, supposing the participation
of other mechanisms.
 
2
 
 Indeed, a pathogenic role for most of
PNP-identified antibodies is still to be determined.
It should be emphasized that when PNP is suspected, it is of
paramount importance to seek an occult neoplasm, especially
with CT scan of the chest, abdomen and pelvis.
 
2
 
Since 1990 
 
1
 
 (Table 2), several diagnostic criteria have been
proposed, although still lacking a consensus about this issue.
In 1993 Camisa and Helm
 
18
 
 proposed a modification of the
Anhalt 
 
et al
 
. criteria (Table 3). In a recent study, from Joly
 
et al
 
.,
 
11
 
 patients with different types of pemphigus associated
or not with neoplasia were reviewed in order to evaluate the
sensitivity and specificity of the diagnostic criteria of PNP.
The conclusion was that one clinical criteria and two biolog-
ical criteria had an elevated sensitivity (82–86%) and specifi-
city (83–100%) for PNP whatever the control group
considered and a re-evaluation of previous diagnostic criteria
was proposed (Table 4). The study also confirmed the accur-
acy of IIF on rat bladder and the high frequency of lympho-
proliferative diseases associated with PNP.
Of the several etiopathogenic mechanisms proposed, the
most consensual include:
 
1
 
The tumor induces a cell-mediated lichenoid interface der-
matitis that will uncover previously hidden antigens.
 
9,17
 
2
 
An immune response against the tumor cross-reacting with
normal epithelial proteins (antigenic mimicry).
 
17
 
3
 
Dysregulation of cytokine production by tumor cells, with
secretion of massive amounts of IL6.
 
1,2,17
 
All or some of these mechanisms can be present in a single
patient, influencing the clinical, histological and immuno-
logical features.
Lichen planus is a mucocutaneous disease that can have sev-
eral triggers, including neoplasms. The few well-characterized
cases of LP in patients with malignancy are related to lichen
planus pemphigoides.
 
19
 
The lichen planus pemphigoides-like variant of PNP is
characterized by tense blisters on previous lichenoid lesions
or normal skin; lichenoid dermatitis on histological examina-
tion and eventual linear IgG and/or C3 deposition at the
dermoepidermal junction on DIF.
 
6
 
 It lacks the circulating
autoantibodies against 200 and 180 kDa epidermal antigens
of LP pemphigoides
 
20
 
 and has the specific array of auto-
antibodies of PNP. However, in some patients with neoplasia
and lichenoid dermatitis, auto-antibodies never occur. These
cases have been designated neoplasia-induced lichen planus.
 
19
 
We think that all these different forms of presentation are
part of an auto-immune reaction mainly humoral in PNP
and mainly cellular in neoplasia induced lichen planus, and
Table 1 PNP autoantigens
 
 
Table 2 Anhalt et al. criteria
 
Desmoplakin I 250 kDa
Desmoplakin II 215 kDa
Bullous pemphigoid antigen I (BPAg I) 230 kDa
Envoplakin 210 kDa
Periplakin 190 kDa
Desmoglein 1 165 kDa
Desmoglein 3 130 kDa
Undetermined trans-membranous antigen 170 kDa
Clinical
Painful mucosal ulcerations and blisters and a polymorphous skin eruption, 
with papular lesions progressing to blisters and erosive lesions on the trunk, 
extremities, palms and soles, in the context of occult neoplasm.
Histologic findings
Vacuolar interface change, keratinocytes necrosis and intra-epidermal 
acantholysis.
DIF
Deposition of IgG and C3 in the intercellular spaces, and granular-linear 
complement deposition along the epidermal basement membrane zone.
IIF
Serum antibodies that bind not only to cell surfaces of skin and mucosa in 
a pattern typical of pemphigus vulgaris, but also to simple, columnar, and 
transitional epithelia.
Immunoprecipitation
Serum antibodies that recognize epidermal antigens of 250, 230, 210, 
190 kDa.
Table 3 Camisa and Helm criteria
 
Table 4 Joly et al. criteria
 
Major criteria
Polymorphous mucocutaneous eruption
Concurrent internal neoplasia
Characteristic serum immunoprecipitation findings
Minor criteria
Positive cytoplasmatic staining of rat bladder by IIF
Intercellular and basement membrane zone immunoreactants on direct 
immunofluorescence of perilesional tissue
Acantholysis in biopsy specimen from at least one anatomic site of 
involvement
High specificity and sensitivity
1. Association with lymphoproliferative disorders
2. IIF positive on rat bladder
3. Immunoblotting detection of antibodies against envoplakin and periplakin
Low sensitivity and high specificity
1. Polymorphous eruption
2. Histology
3. DIF
4. Immunoblotting detection of antibodies against desmoplakins and BPAGI
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evidence suggests that there are similar triggers. Why the
different inaugural characteristics, sometimes with the same
underlying neoplasm, is still obscure. It is also difficult to
explain why in some patients, the clinical, histological and
immunological features change over time with the appear-
ance of acantholysis and autoantibodies,
 
9
 
 while in others this
never happens.
 
19
 
 The term PNP should therefore be applied to
patients that in spite of lichenoid lesions have the specific
autoantibodies.
The prognosis of PNP associated with malignant neo-
plasms is poor with a rapidly fatal outcome in a few
months.
 
1,3
 
 Camisa 
 
et al
 
. report a case of prolonged survival
suggesting a subgroup with a more favorable outcome.
 
21
 
 It
seems that with indolent B-cell lymphomas, the paraneoplas-
tic reaction could offer some protection against the progres-
sion of the disease.
 
18
 
 It should be kept in mind that disease
progression doesn’t parallel that of the neoplasm, as observed
in our patient.
These neoplasms have been associated with other paraneo-
plastic syndromes, and some suggest the name “paraneoplas-
tic autoimmune multiorgan syndrome” PAMS.
 
22
 
A particularity of our clinical report was the absence of
aggressive involvement of the oral mucosa. The patient
also showed good response to oral corticotherapy, with a
prolonged remission. The deep vein thrombosis was, in our
opinion, another paraneoplastic manifestation and the
presence of antinuclear antibodies an evidence of a patent
dysimmunoreactivity.
 
23
 
PNP manifested has lichenoid eruptions is more common
then previously accepted and the potential role of cell-mediated
immunity at the DEJ as a participant in the pathogenesis of
PNP can’t be underestimated.
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